Quince Therapeutics Inc 2026年季度报告

Quince Therapeutics, Inc.(Exact name of registrant as specified in its charter) Registrant’s telephone number, including area code: (415) 910-5717 Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered The Nasdaq Stock Market LLC Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during thepreceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of RegulationS-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerginggrowth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisedfinancial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒ As of May 4, 2026, the registrant had 16,300,740 shares of common stock, $0.001 par value per share, outstanding. EXPLANATORY NOTEOn April 10, 2026, the Company effected a reverse stock split of all shares of its issued and outstanding common stock at a ratio of 1-for-10. The Company accounted for the reverse stock split on a retrospective basis pursuant to Accounting Standards Codification (“ASC”) 260, Earnings Per Share. All issued and outstanding shares of common stock and share-based awards’exercise prices and per share data in this report and the unaudited condensed consolidated financial statements have been adjusted, on a retrospective basis, to reflect the reverse stock splitfor all periods presented. The number of authorized shares and par value of the common stock were not adjusted because of the reverse stock split. Table of Contents FINANCIAL INFORMATIONFinancial Statements (Unaudited)1Condensed Consolidated Balance Sheets (Unaudited)1Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)2Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited)3Condensed Consolidated Statements of Cash Flows (Unaudited)4Notes to Unaudited Condensed Consolidated Financial Statements5Management’s Discussion and Analysis of Financial Condition and Results of Operations27Quantitative and Qualitative Disclosures About Market Risk35Controls and Procedures35 PART II. Item 1.Legal Proceedings36Item 1A.Risk Factors36Item 2.Unregistered Sales of Equity Securities and Use of Proceeds37Item 3.Defaults Upon Senior Securities37Item 4.Mine Safety Disclosures37Item 5.Other Information37Item 6.Exhibits38Signatures40 Special Note Regarding Forward-Looking Statements This Quarterly Report on Form 10-Q contains forward-looking statements. All statements other than statements of historical factscontained in this report, including statements regarding our future results of operations and financial position, business strategy,drug candidates, planned preclinical studies and clinical trials, research and development costs, regulatory approvals, timing andlikelihood of success, as well as plans and objectives of management for future operations, are forward-looking statements. In somecases, forward-looking statements may be identified by words such as "believe," "may," "will," "estimate," "continue," "anticipate,""intend," "could," "would," "expect," "objective," "plan," "potential," "seek," "grow," "target," "if," and similar expressionsintended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trendsthat we believe may affect our financial condition, results of operations, business strategy, short-term and long-term businessoperations and objectives and financial needs. These forward-looking statements are subject to known and unknown risks,uncertainties and assumptions, including risks described in the section titled “Risk Factors” set forth in Part II, Item 1A of thisQuarterly Report on Form 10-Q and in our other filings with the Securities and Exchange Commission (the "SEC"). It is notpossible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to whichan